Home

bohatství úzkost flétna os overall survival trm halda Částečný Oslabit

Experience of the Spanish Group for Hematopoietic Transplantation  (GETMON-GETH) in allogenic Hematopoietic stem cell Transplantation in  Philadelphia acute lymphoblastic leukemia - ScienceDirect
Experience of the Spanish Group for Hematopoietic Transplantation (GETMON-GETH) in allogenic Hematopoietic stem cell Transplantation in Philadelphia acute lymphoblastic leukemia - ScienceDirect

Experience of the Spanish Group for Hematopoietic Transplantation  (GETMON-GETH) in allogenic Hematopoietic stem cell Transplantation in  Philadelphia acute lymphoblastic leukemia | Anales de Pediatría
Experience of the Spanish Group for Hematopoietic Transplantation (GETMON-GETH) in allogenic Hematopoietic stem cell Transplantation in Philadelphia acute lymphoblastic leukemia | Anales de Pediatría

Efficacy and safety of mesenchymal stem cells treatment for  multidrug-resistant graft-versus-host disease after haploidentical  allogeneic hematopoietic stem cell transplantation - Meng-Zhu Shen, Xin-Xin  Liu, Zhi-Yuan Qiu, Lan-Ping Xu, Xiao-Hui Zhang ...
Efficacy and safety of mesenchymal stem cells treatment for multidrug-resistant graft-versus-host disease after haploidentical allogeneic hematopoietic stem cell transplantation - Meng-Zhu Shen, Xin-Xin Liu, Zhi-Yuan Qiu, Lan-Ping Xu, Xiao-Hui Zhang ...

Musa Baris Aykan arşivleri - Medicine Science
Musa Baris Aykan arşivleri - Medicine Science

Fifteen year overall survival rates after autologous stem cell  transplantation for AL amyloidosis - Sidana - 2019 - American Journal of  Hematology - Wiley Online Library
Fifteen year overall survival rates after autologous stem cell transplantation for AL amyloidosis - Sidana - 2019 - American Journal of Hematology - Wiley Online Library

Factors responsible for long-term survival in metastatic breast cancer |  World Journal of Surgical Oncology | Full Text
Factors responsible for long-term survival in metastatic breast cancer | World Journal of Surgical Oncology | Full Text

Long-Term Overall Survival From KEYNOTE-021 Cohort G: Pemetrexed and  Carboplatin With or Without Pembrolizumab as First-Line Therapy for  Advanced Nonsquamous NSCLC - Journal of Thoracic Oncology
Long-Term Overall Survival From KEYNOTE-021 Cohort G: Pemetrexed and Carboplatin With or Without Pembrolizumab as First-Line Therapy for Advanced Nonsquamous NSCLC - Journal of Thoracic Oncology

Prognostic Significance of NPM1 Mutations in the Absence of FLT3–Internal  Tandem Duplication in Older Patients With Acute Myeloid Leukemia: A SWOG  and UK National Cancer Research Institute/Medical Research Council Report |  Journal
Prognostic Significance of NPM1 Mutations in the Absence of FLT3–Internal Tandem Duplication in Older Patients With Acute Myeloid Leukemia: A SWOG and UK National Cancer Research Institute/Medical Research Council Report | Journal

Osimertinib versus platinum–pemetrexed for patients with EGFR T790M  advanced NSCLC and progression on a prior EGFR-tyrosine kinase inhibitor:  AURA3 overall survival analysis - Annals of Oncology
Osimertinib versus platinum–pemetrexed for patients with EGFR T790M advanced NSCLC and progression on a prior EGFR-tyrosine kinase inhibitor: AURA3 overall survival analysis - Annals of Oncology

Hematopoietic stem cell transplantation for thalassemia major using HLA  fully-matched and mismatched donor grafts - Huang - Translational Pediatrics
Hematopoietic stem cell transplantation for thalassemia major using HLA fully-matched and mismatched donor grafts - Huang - Translational Pediatrics

Frontiers | Outcomes of Newly Diagnosed Acute Myeloid Leukemia Patients  Treated With Hypomethylating Agents With or Without Venetoclax: A  Propensity Score-Adjusted Cohort Study
Frontiers | Outcomes of Newly Diagnosed Acute Myeloid Leukemia Patients Treated With Hypomethylating Agents With or Without Venetoclax: A Propensity Score-Adjusted Cohort Study

Factors predicting long-term survival after T-cell depleted reduced  intensity allogeneic stem cell transplantation for acute myeloid leukemia |  Haematologica
Factors predicting long-term survival after T-cell depleted reduced intensity allogeneic stem cell transplantation for acute myeloid leukemia | Haematologica

The association between CD8+ tumor-infiltrating lymphocytes and the  clinical outcome of cancer immunotherapy: A systematic review and  meta-analysis - eClinicalMedicine
The association between CD8+ tumor-infiltrating lymphocytes and the clinical outcome of cancer immunotherapy: A systematic review and meta-analysis - eClinicalMedicine

Phase II Clinical Trial of Allodepleted T Cell Immunotherapy (ATIR101)  Post-Transplant Results in Decreased Transplant-Related Mortality and  Improved Survival in Acute Leukemia Patients Undergoing T-Depleted  Haploidentical Stem Cell Transplantation ...
Phase II Clinical Trial of Allodepleted T Cell Immunotherapy (ATIR101) Post-Transplant Results in Decreased Transplant-Related Mortality and Improved Survival in Acute Leukemia Patients Undergoing T-Depleted Haploidentical Stem Cell Transplantation ...

Three-year probability of overall survival (OS), disease-free survival... |  Download Scientific Diagram
Three-year probability of overall survival (OS), disease-free survival... | Download Scientific Diagram

Transplant‐related mortality following allogeneic hematopoeitic stem cell  transplantation for pediatric acute lymphoblastic leukemia: 25‐year  retrospective review - Mateos - 2013 - Pediatric Blood & Cancer - Wiley  Online Library
Transplant‐related mortality following allogeneic hematopoeitic stem cell transplantation for pediatric acute lymphoblastic leukemia: 25‐year retrospective review - Mateos - 2013 - Pediatric Blood & Cancer - Wiley Online Library

CD103+CD8+ TRM Cells Accumulate in Tumors of Anti-PD-1-Responder Lung  Cancer Patients and Are Tumor-Reactive Lymphocytes Enriched with Tc17 -  ScienceDirect
CD103+CD8+ TRM Cells Accumulate in Tumors of Anti-PD-1-Responder Lung Cancer Patients and Are Tumor-Reactive Lymphocytes Enriched with Tc17 - ScienceDirect

Long-term event-free and overall survival after risk-adapted melphalan and  SCT for systemic light chain amyloidosis | Leukemia
Long-term event-free and overall survival after risk-adapted melphalan and SCT for systemic light chain amyloidosis | Leukemia

IJMS | Free Full-Text | An Eleven-microRNA Signature Related to  Tumor-Associated Macrophages Predicts Prognosis of Breast Cancer | HTML
IJMS | Free Full-Text | An Eleven-microRNA Signature Related to Tumor-Associated Macrophages Predicts Prognosis of Breast Cancer | HTML

Cd8 (Abcam) | Bioz | Ratings For Life-Science Research
Cd8 (Abcam) | Bioz | Ratings For Life-Science Research

Overall survival (OS) and relative survival by treatment intensity and... |  Download Scientific Diagram
Overall survival (OS) and relative survival by treatment intensity and... | Download Scientific Diagram

Allogeneic Hematopoietic Stem Cell Transplantation Using Reduced-Intensity  Conditioning for Adult T Cell Leukemia/Lymphoma: Impact of Antithymocyte  Globulin on Clinical Outcome - Biology of Blood and Marrow Transplantation
Allogeneic Hematopoietic Stem Cell Transplantation Using Reduced-Intensity Conditioning for Adult T Cell Leukemia/Lymphoma: Impact of Antithymocyte Globulin on Clinical Outcome - Biology of Blood and Marrow Transplantation

Validity of the Minnesota aGvHD risk score in predicting survival and  response to therapy
Validity of the Minnesota aGvHD risk score in predicting survival and response to therapy

Is stem cell transplantation still needed for adult Philadelphia  chromosome-positive acute lymphoblastic leukemia receiving tyrosine kinase  inhibitors therapy?: A systematic review and meta-analysis | PLOS ONE
Is stem cell transplantation still needed for adult Philadelphia chromosome-positive acute lymphoblastic leukemia receiving tyrosine kinase inhibitors therapy?: A systematic review and meta-analysis | PLOS ONE

Outcomes of adults with acute myelogenous leukemia in remission given 550  cGy of single-exposure total body irradiation, cyclophosphamide, and  unrelated donor bone marrow transplants - Biology of Blood and Marrow  Transplantation
Outcomes of adults with acute myelogenous leukemia in remission given 550 cGy of single-exposure total body irradiation, cyclophosphamide, and unrelated donor bone marrow transplants - Biology of Blood and Marrow Transplantation

High proportions of CD3+ T cells in grafts delayed lymphocyte recovery and  reduced overall survival in haploidentical peripheral blood stem cell  transplantation
High proportions of CD3+ T cells in grafts delayed lymphocyte recovery and reduced overall survival in haploidentical peripheral blood stem cell transplantation

Tissue-resident memory T cells in gastrointestinal cancer immunology and  immunotherapy: ready for prime time? | Journal for ImmunoTherapy of Cancer
Tissue-resident memory T cells in gastrointestinal cancer immunology and immunotherapy: ready for prime time? | Journal for ImmunoTherapy of Cancer

Figure 1 | Reduced risk of chronic GVHD by low-dose rATG in adult matched  sibling donor peripheral blood stem cell transplantation for hematologic  malignancies | SpringerLink
Figure 1 | Reduced risk of chronic GVHD by low-dose rATG in adult matched sibling donor peripheral blood stem cell transplantation for hematologic malignancies | SpringerLink